Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Grifols, S.A.

Spain

CMS manufacturer 100000005425

Open in the dashboard

General payments

$3,916,130

181 payments

Research payments

$2,209,045

253 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Grifols, S.A. reported paying $3,916,130 in general payments and $2,209,045 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $16,109 5
2024 General $42,687 19
2024 Research $27,465 1
2023 General $74,087 15
2022 General $210,767 60
2022 Research $111,597 27
2021 General $3,524,429 53
2021 Research $2,069,983 225
2020 General $21,629 9
2019 General $26,423 20

Breakdown

Top recipients General payments · program year 2025
  1. Jerrold Levy Anesthesiology · Durham, NC $5,539 2 payments
  2. George Rodgers Hematology · Salt Lake City, UT $3,540 1 payment
  3. Mark Ballow Pediatric Allergy/Immunology · Tampa, FL $3,540 1 payment
  4. Gregory Martin Pulmonary Disease · Atlanta, GA $3,489 1 payment
Top research recipients Research payments · program year 2024
  1. Ohio State University Research Compliance $27,465 1 payment
Products the payments named General payments · program year 2025
  1. Thrombate III Hematology $7,029 67% · 2 recipients
  2. Albutein Critical Care Medicine $3,489 33% · 1 recipient

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Anesthesiology $5,539 34% · 1 practitioner
  2. Hematology Internal Medicine $3,540 22% · 1 practitioner
  3. Pediatric Allergy/Immunology Pediatrics $3,540 22% · 1 practitioner
  4. Pulmonary Disease Internal Medicine $3,489 22% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. North Carolina $5,539 34% · 1 recipient
  2. Florida $3,540 22% · 1 recipient
  3. Utah $3,540 22% · 1 recipient
  4. Georgia $3,489 22% · 1 recipient

Each share is of this company’s general payments in 2025 where a state was reported.

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $3,806,691 114 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $54,404 19 payments
  3. Honoraria $46,495 22 payments
  4. Travel and Lodging $6,689 11 payments
  5. Food and Beverage $1,350 14 payments
  6. Education $500 1 payment
Companies with a similar name General payments · program years 2019–2025
  1. Grifols USA, LLC CA, United States $9,592,710
  2. Grifols Shared Services North America, Inc. CA, United States $1,361,493
  3. Grifols Diagnostic Solutions, Inc. CA, United States $142,827
  4. Grifols Biologicals LLC CA, United States $113,108
  5. Grifols Therapeutics LLC CA, United States $27,907
  6. Grifols Canada Ltd. Canada $14,900

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

181 general · 253 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record